Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 367 institutions that hold shares in the stock, with a total of 184 Million shares, which have been reported (via 13F filing form) to have a value of $8.61 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Viking Global Investors LP
|
May 15, 2025 Q1 2025 |
22,055,375
shares
|
$1.01 Billion
2.55% of portfolio
|
Q1 2025
Reduced 12.2%
|
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
May 15, 2025 Q1 2025 |
19,260,971
shares
|
$884 Million
30.7% of portfolio
|
Q1 2025
Reduced 23.75%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
14,900,145
shares
|
$684 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.18%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
12,448,272
shares
|
$571 Million
0.01% of portfolio
|
Q2 2024
Added 18.93%
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
7,171,399
shares
|
$329 Million
0.14% of portfolio
|
Q1 2025
Added 46.13%
|
|
Aisling Capital Management LP
New York, NY |
May 13, 2025 Q1 2025 |
6,068,125
shares
|
$279 Million
73.33% of portfolio
|
Q1 2021
Added 52.11%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
5,749,619
shares
|
$264 Million
0.01% of portfolio
|
Q1 2025
Reduced 7.0%
|
|
Farallon Capital Management LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
5,731,000
shares
|
$263 Million
1.14% of portfolio
|
Q1 2025
Added 36.62%
|
|
Capital Research Global Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
4,667,402
shares
|
$214 Million
0.04% of portfolio
|
Q1 2025
Added 32.34%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
3,800,457
shares
|
$174 Million
8.27% of portfolio
|
Q4 2024
Added 1.06%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,502,894
shares
|
$161 Million
0.01% of portfolio
|
Q1 2025
Added 2.49%
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2025 Q1 2025 |
2,978,167
shares
|
$137 Million
2.67% of portfolio
|
Q1 2025
Reduced 20.39%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
2,931,033
shares
|
$135 Million
0.02% of portfolio
|
Q1 2025
Added 133.48%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
2,800,000
shares
|
$129 Million
3.38% of portfolio
|
Q1 2025
Added 241.81%
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
2,684,146
shares
|
$123 Million
0.04% of portfolio
|
Q1 2025
Reduced 3.94%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,532,716
shares
|
$116 Million
0.05% of portfolio
|
Q2 2023
Added 75.59%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
2,223,308
shares
|
$102 Million
0.01% of portfolio
|
Q1 2025
Reduced 6.91%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
2,206,163
shares
|
$101 Million
0.02% of portfolio
|
Q1 2025
Added 147.02%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,198,514
shares
|
$101 Million
0.01% of portfolio
|
Q1 2025
Added 19.49%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
2,090,268
shares
|
$95.9 Million
0.08% of portfolio
|
Q1 2025
Added 15.65%
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
2,000,000
shares
|
$91.8 Million
7.33% of portfolio
|
Q1 2025
Added 25.0%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
1,887,763
shares
|
$86.6 Million
0.07% of portfolio
|
Q1 2025
Added 0.1%
|
|
Sc Us (Ttgp), Ltd.
Menlo Park, CA |
May 14, 2025 Q1 2025 |
1,860,364
shares
|
$85.4 Million
0.68% of portfolio
|
Q2 2021
Reduced 26.89%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
1,850,039
shares
|
$84.9 Million
0.13% of portfolio
|
Q1 2025
Reduced 6.34%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,625,755
shares
|
$74.6 Million
0.39% of portfolio
|
Q1 2025
Reduced 26.49%
|